Suche
Mein Konto
LPT Treatment for Arthritis: InnoCan Pharma Announces Clinical Trial Results for Liposomal CBD Pain Relief in Dogs
According to a report from www.finanznachrichten.de, the company InnoCan Pharma recently published promising results from clinical studies. The studies show the positive effects of liposomal CBD in the treatment of arthritis and epilepsy in dogs. Injection of liposomal CBD resulted in significant pain relief and improved quality of life in the treated animals. The results of these studies are groundbreaking and could potentially have an impact on the market and the financial industry. CBD is becoming increasingly popular and the demand for CBD products is constantly increasing. The use of liposomal CBD as a treatment option for arthritis and epilepsy in dogs could lead to a new market segment and...
LPT Treatment for Arthritis: InnoCan Pharma Announces Clinical Trial Results for Liposomal CBD Pain Relief in Dogs
According to a report from www.finanznachrichten.de, the company InnoCan Pharma recently published promising results from clinical studies. The studies show the positive effects of liposomal CBD in the treatment of arthritis and epilepsy in dogs. Injection of liposomal CBD resulted in significant pain relief and improved quality of life in the treated animals.
The results of these studies are groundbreaking and could potentially have an impact on the market and the financial industry. CBD is becoming increasingly popular and the demand for CBD products is constantly increasing. Die Verwendung von liposomalem CBD als Behandlungsoption für Arthritis und Epilepsie bei Hunden könnte zu einem neuen Marktsegment führen und das Potenzial für innovative Produkte eröffnen.
In addition, InnoCan Pharma has also achieved success in developing CBD products for humans. The company's Relief & Go pain relief spray produced pain reduction in 95% of users. Another product, SHIR Premium CBD Facial Serum, reduced wrinkles by 90% in a clinical study.
These successes demonstrate the enormous potential of InnoCan Pharma in the biotech industry. The company combines CBD with innovative technologies such as liposomal CBD and exosomes to treat various diseases and conditions. Initial studies have shown promising results and could lead to advances in medical treatment.
InnoCan Pharma has a top-class management team and a scientific advisory board consisting of experts from the pharmaceutical industry. This expertise and the company's potential make it an interesting investment opportunity. It is expected that InnoCan Pharma shares could benefit from these positive developments.
However, it is important to note that any investment in securities involves risks. Investments in small and medium-sized companies in particular involve a higher risk. Investors should carefully consider their decisions and inform themselves about the potential risks and opportunities.
Source: According to a report from www.finanznachrichten.de
Read the source article at www.finanznachrichten.de